Joseph L. Nates
- Dr. Joseph L. Nates is a professor at the University of Texas MD Anderson Cancer Center, where he serves as the Deputy Chair and Patient Safety and Quality Officer of the Department of Critical Care in the Division of Anesthesiology, Critical Care, and Pain Medicine. He previously served as the Medical Director of the Onco-Hematologic Surgical and Medical Intensive Care Units at MD Anderson Cancer Center, as well as the Neuro-Intensive Care Unit and Neuro-Critical Care Program at Memorial-Hermann Hospital in Houston.
- Dr. Nates is the Founder and President of the Oncologic Critical Care Network (ONCCC-R-NET), a global organization dedicated to advancing oncologic critical care research and education. He has been at the forefront of establishing Oncologic Critical Care as a new subspecialty and spreading this knowledge worldwide. To achieve this goal, he has led and co-authored the first two comprehensive oncologic critical care textbooks in both Spanish and English. He has also authored over 400 scientific publications, including peer-reviewed articles, editorials, books, manuals, and book chapters. Additionally, he has established regional and global collaborative networks and organized several Oncologic Critical Care symposiums.
- In recognition of his contributions to critical care, Dr. Nates was awarded the title of Master of Critical Care Medicine by the American College of Critical Care Medicine in 2018. The same year, he received the International Master of Critical Care Medicine award from the Chilean Society of Critical Care and Emergency Medicine for his global contributions to the development of Oncologic Critical Care.
- In 2022, Dr. Nates became the Founding President of the Global Oncologic Critical Care Society.
PhD, Nobel Laureate
- Dr. James Allison is the Regental Professor and Chair of the Department of Immunology, Vice President of Immunobiology, Executive Director of Immunotherapy Platform, Director of the Parker Institute for Cancer Research, Deputy Director for David H. Koch Center for Applied Research for Genitourinary Cancers, the Olga Keith Wiess Distinguished University Chair of Cancer Research. He is the founding director of the James P. Allison Institute, established in 2022.
- Dr. Allison has spent a distinguished career studying the regulation of T cell responses and developing strategies for cancer immunotherapy. He earned the 2018 Nobel Prize in Physiology or Medicine, which he shared with Dr. Tasuku Honjo; for their discovery of cancer therapy by inhibition of negative immune regulation.
- Among his most notable discoveries are the determination of the T cell receptor structure and that
CD28 is the major costimulatory molecule that allows full activation of naïve Tcells and prevents energy in T cell clones.
- His lab resolved a major controversy by demonstrating that CTLA-4 inhibits T-cell activation by opposing CD28-mediated costimulation and that blockade of CTLA-4 could enhance T cell responses, leading to tumor rejection in animal models.
- This finding paved the wave for the emerging field of immune checkpoint blockade therapy for cancer. Work in his lab led to the development of ipilimumab, an antibody to human CTLA-4 and the first immune checkpoint blockade therapy approved by the FDA. Among many honors, he is a member of the National Academies of Science and Medicine and received the Lasker-Debakey Clinical Medical Research award, the Kovalenko Medal, the Balzan Prize, the Tang Prize, and the Benjamin Franklin Medal.
- Ongoing work in his laboratory seeks to improve immune checkpoint blockade therapies currently used by our clinicians and identify new targets to unleash the immune system to eradicate cancer.
- Dr. Elie Azoulay is Professor of Medicine, Specialty Pulmonary Medicine and Intensive Care Medicine, at the University of Paris-Cité and Faculty of Medicine, and heaf of the critical care department at the Saint Louis Hospital, Paris.
- Dr. Azoulay has coordinated and directed several research groups, including the French FAMIREA Study Group aimed at improving the effectiveness of communication with family members of intensive care unit (ICU); the GRRR-OH research group for the management and outcomes of acute respiratory failure in critically ill immunocompromised patients; and the Nine-I study multinational collaborative group working on immunocompromised patients. His main lines of scholarly inquiry surround acute respiratory failure in immunocompromised patients, non-invasive mechanical ventilation, hematological malignancies in the intensive care unit, and other hematological emergencies. Most of his publications have been seminal studies in the discipline of intensive care medicine, especially in the areas of critical care of immunocompromised patients and ethics. He has published 502 articles, 121 reviews, 40 editorials, and 53 letters, which have been cited 69,257 times, with an H-index of 138 (Google Scholar).
- Dr. Azoulay served as Editor-in-Chief of Intensive Care Medicine. Under his leadership, the journal’s impact factor grew to the highest in its history, placing it at the top of journals in the field of critical care medicine. He has also served as editor in many other journals, and is in the advisory board of the Lancet respiratory Medicine.
- He is currently the President of the European Society of Intensive Care Medicine (ESICM).
- Dr. Marcio Borges is an Associate Professor of Infectious Diseases at the University of the Balearic Islands (UIB) and Coordinator of the Multidisciplinary Sepsis Unit, Department of Intensive Care Medicine, Hospital Universitario Son Llatzer in Palma de Mallorca from 2009 to present.
- Principal Investigator of the Sepsis Group of the Institute for Scientific Research of the Balearic Islands (IDISBA)
- National Coordinator of the Sepsis Code Plan in Spain
- Coordinator of the National Consensus Document Sepsis Code with the support of the Ministry of Health and Consumption of Spain.
- Director of the sepsis committee of FEPIMCTI
- President of the Sepsis Code Foundation, Ministry of Education since 2018.
- Member of the Board of Directors of the Spanish Society of Chemotherapy (SEQ) since 2018.
- Member of the Micellium Foundation since 2010, Ministry of Education.
- Independent external collaborating advisor to the Pan American Health Organization and the World Health Organization (PAHO-WHO) since 2020.
- Main author and co-author of more than 400 indexed national and international scientific publications.
- Editor of 12 books. Main author and co-author of more than 300 and 450, respectively, oral communications/posters in national and international congresses.
- Organizer/director of more than 70 infectious diseases and sepsis training courses.
- Dr. Craig Coopersmith is the Director of the Emory Critical Care Center. He is also Professor of Surgery at Emory University School of Medicine.
- Dr. Coopersmith is currently the Principal Investigator or co-Principal Investigator on multiple research grants from the National Institutes of Health related to his work on the gut in sepsis and the immune response to sepsis. He is also the Principal Investigator on a NIH-funded T32 training grant on critical care.
- Dr. Coopersmith co-chairs the steering committee and the research arm of the Surviving Sepsis Campaign and serves on its executive committee.
- Dr. Coopersmith currently serves on the national guidelines panel for COVID-19 management sponsored by the NIH and has advised the World Health Organization on COVID-19.
- Dr. Coopersmith is past-president of the Society of Critical Care Medicine as well as a past chair of Discovery, the Critical Care Research Network. He is also the 2023 recipient of the American College of Critical Care Medicine
- Distinguished Investigator Award.
Jigeeshu V. Divatia
- Professor and Head, Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Mumbai.
- President-Elect, Indian Society of Anaesthesiologists
- Past-President of the Indian Society of Critical Care Medicine
- Past-President, All-India Difficult Airway Association and Society of Oncoanaesthesia and Critical Care Editor-in-Chief, Airway Past Editor-in-Chief, Indian Journal of Anaesthesia
- Major Interests: Mechnaical Ventilation, Haemodynamics, ICU organisation and End-of-life care, Airway management,
- H-index 40
- Reviewer for several national and international journals
- Over 189 publications in national and international journals international journals
MD, PhD, FESC
- Is a cardiologist (2000) with further specialization in intensive care (2003). She is responsible for the Coronary Care unit in the University Hospital of Ghent, Belgium where she is involved in several interdisciplinary clinics aiming at excellent patient care: cardiac disease during pregnancy, acute aortic disease, TAVI, cardiogenic shock, cardiac arrest.
- She was appointed assistant professor in cardiology at the University of Ghent in 2018 (5%).
- She has clinical and research interest in acute cardiac disease, especially in women (e.g. pregnancy, SCAD, acute heart failure) and cancer patients.
- She is an ex-officio board member of ACVC (acute cardiovascular care association of ESC), ACVC representative in the council of Cardio-Oncology of the ESC and board member of the BIWAC (Belgian interdisciplinary working group on acute cardiology).
She was member of the task force of the 2022 ESC guidelines on cardio-oncology and first author of 2 consensus documents on acute cardiac disease in cancer patients.
- Dr. Gottumukkala is a Professor of Anesthesiology & Perioperative Medicine at the University of Texas MD Anderson Cancer Center (MDACC), Houston, USA.
He currently serves MDACC asthe institutional lead for Enhanced Recovery Programs, as the Medical Director for the Program for Advancement of Perioperative Cancer CarE (PACE), and as an Associate Head for the Institute for Cancer Care Innovation (ICCI).
- He leads the institutional Enhanced Recovery Program at MDACC (the largest patient-centred, recovery-focused, outcomes-driven, value-based care program for oncology patients in the world).
- His clinical research interest is in evaluating the role of perioperative clinical strategies and pathways to standardize care and improve oncological outcomes.
- Dr. Gottumukkala’s academic interests are: Enhanced Recovery Protocols in major cancer surgery, and to develop Onco-Anesthesiology as a specialty.
- He is actively engaged with the professional societies at the state, national and international level.
- He serves as the scientific and education committee Chair for the Texas Society of Anesthesiologists (TSA); as an alternate delegate from TSA to the American Society of Anesthesiologists (ASA); on the Board for the American Society for Enhanced Recovery and Perioperative Medicine (ASER- POM), currently serving as the President-Elect; and as an Advisory Member for Evidence Based Perioperative Medicine-USA.
- Dr. Cristina Gutiérrez is an Associate Professor of Critical Care Medicine at MD Anderson Cancer Center.
- She finished medical school in the Universidad La Sabana in Colombia and moved to the United States to do research as a Neuro-Immunology post-doctoral fellow at Brigham and Women’s Hospital in Boston, MA.
- She later moved to New York City where she completed her Internal Medicine residency, followed by a Critical Care fellowship at Memorial Sloan Kettering Cancer Center.
- It was this experience that introduced her to the complexities of care of the critically ill oncological patient.
- After practicing in New York for three years, she moved to Houston to join MD Anderson where she could pursue her two passions: research and patient care.
- Her research efforts are mainly focused on evaluating the effects of immune based therapies, their complications, and implications of their use in critically ill patients.
- She’s been the principal investigator in more than fourteen studies, all of which have led to important publications.
- She continues to lead and prioritize research efforts within the US in the area of oncological critical care and hopes to reach a larger Critical Care community to improve the management of these patients.
Alfredo A. Matos Adames
- Especialista en Cirugía General
Specialist in General Surgery
- Especialista en Medicina Crítica y Terapia Intensiva
Specialist in Critical Medicine and Intensive Care Medicine
- Maestría en Administración en Salud
Master’s Degree in Health Administration
- Maestría en Docencia Superior
Master’s Degree in Higher Education
- Posgrado en Farmacoeconomía
Postgraduate in Pharmacoeconomics
- Jefe de la UCI de Cirugía Complejo Hospitalario CSS
Head of Surgery ICU, CSS Hospital Complex
- Profesor de Cirugía, Propedéutica y Nutrición
Professor of Surgery, Propaedeutics and Nutrition
- Facultad de Medicina - Universidad de Panamá
Faculty of Medicine – University of Panama
- Presidente de la FEPIMCTI
President of FEPIMCTI
María Cruz Martin Delgado
- Head of Intensive Care Department // Associated professor
- 12 de Octubre University Hospital// Complutense University of Madrid (CUM)
- 2011-2022 Head of Intensive Care Department Torrejón University Hospital
- 2016- Currently . Associated professor Francisco de Vitoria University
- 2010-2011 Coordinator of the Emergency Department Henares University Hospital
2007-2009 Head of Intensive Care Department and Emergency Department Vic Hospital Consortion
- 2004-2007 Clinical Chieff of Intensive Care Unit of the Delfos Medical Center
- 1996-2004 Staff Intensive Care Unit of General Catalonian Hospital
- 1996 Staff Intensive Care Unit Vall d’Hebron University Hospital.
- PhD (Doctor in Medicine) Autonomous University of Barcelona 1998
- Training specialist ICU Vall d’Hebron University Hospital. 1991-1995
- Medicine Degree Central University of Barcelona 1984-1990
- Master in Bioethics and Law Central University of Barcelona 2000-2002
- Master in Management of Health Centers and Services Virtual University of Barcelona 2002-2004.
- Master in quality care and patient Safety European Institute of Health and Social Welfare. 2009-2010
- Dr. Colleen McEvoy is an Associate Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Washington University School of Medicine.
- She is also the Medical Director of the Stem Cell Transplant and Oncology ICU, Associate Director of the Pulmonary Hypertension Care Center, and Co-Director of the COVID Critical Care Task Force.
- Dr. McEvoy earned her medical doctorate at the University of Missouri, Columbia School of Medicine.
- She completed her internal medicine residency at Northwestern University in Chicago, and fellowship in Pulmonary and Critical Care at Washington University and Barnes-Jewish Hospital.
- Dr. McEvoy is actively involved in many professional committees within the university and Barnes-Jewish Hospitals, including the Critical Care Committee, Center of Gene and Cellular Immunotherapy, and the Patient Safety Committee for Tracheostomy Care.
Her clinical research focuses on pulmonary vascular disease with multiple ongoing trials in pulmonary arterial hypertension.
She also has a clinical interest in the development, prevention and management of pulmonary graft versus host disease after bone marrow transplantation.
- Dr Victoria Metaxa is a full-time Critical Care and Major Trauma Consultant, at King’s College Hospital in London.
- She is a King's College London Honorary Clinical Senior Lecturer, and has a PhD in neurosciences and an MA in Medical Ethics and Palliative Care from Keele University.
- Her clinical interests include bioethics, end-of-life care, critical care outreach and the management of patients with haematological malignancies.
- Dr Metaxa is a member of the European Society of Intensive Care (ESICM) Ethics section, and the representative of the section in the e-learning committee.
- She is the UK National Outreach Forum board Secretary and a member of the Legal and Ethical Advisory Group of the UK Intensive Care Society (ICS).
- Dr. Laveena Munshi Associate Professor, Clinician Scientist, Interdepartmental Division of Critical Medicine, University of Toronto.
- Laveena Munshi is a Clinician Scientist and Associate Professor in the Interdepartmental Division of Critical Medicine.
- She is based at Sinai Health System/ University Health Network (University of Toronto) and has a clinical and research interest in the critical care management of patients with cancer.
- She is the co- founder of the Critical Care Oncologic Investigative Network (COIN).
- She has recently received funding to evaluate subphenotypes of respiratory failure across immunocompromised patients.
Silvio A. Ñamendys-Silva
MD, MSc, FCCP, FCCM
- Internal Medicine & Critical Care Medicine
- Program Director, Critical Care Medicine, Department of Critical Care Medicine, Instituto Nacional de Cancerología, México
Positions and Honors
- Fellow of College of Chest Physicians. 10/2008-present
- Fellow of Critical Care Medicine. 02/2019-present Director, Department of Critical Care Medicine, Instituto Nacional de Cancerología, Mexico City, Mexico. 03/2007-present
- Clinical research, Department of Critical Care Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 06/2006-present
- Past President of the Mexican Board of Critical Care Medicine (03/2014-03/2016)
National Researcher Level 2 (Mexico) 2023-2027
- Program Director, Critical Care Medicine, Department of Critical Care Medicine, Instituto Nacional de Cancerología, Mexico City, Mexico. Universidad Nacional Autónoma de México. 03/214-present
- American College of Chest Physicians. 2006-present
- American Thoracic Society. 2006-present
- Society of Critical Care Medicine. 2007-present
- Sandra Olaya is a Gynecologist (The South Colombian University).
- Specialized in critical care medicine (the Fundacion Universitaria de Ciencias de la Salud), PhD in Education from Tolima University.
- Professor at the University of Manizales, Universidad Autonoma de Manizales.
- Coordinator of the obstetric intensive care unit of the San Jorge de Pereira Hospital and SES Hospital in Caldas.
- She is also the Director of the obstetric critical care committee of the FEPIMCTI.
Stephen M. Pastores
MD, MACP, FCCP, FCCM
- Dr. Pastores is the Director of the Critical Care Medicine Fellowship Program and Vice-Chair of Education in the Department of Anesthesiology and Critical Care Medicine at Memorial Sloan Kettering Cancer Center in New York City.
- He is a Professor of Medicine in Anesthesiology and Medicine at Weill Cornell Medical College.
- He completed internal medicine training including chief residency at the Metropolitan Hospital Center in New York, pulmonary and critical care medicine fellowship at NYU-Bellevue Hospital, and critical care medicine fellowship at Mount Sinai Medical Center in New York.
- He is Board Certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.
- He is a Master of the American College of Physicians, a Fellow of the American College of Critical Care Medicine and American College of Chest Physicians, and past Chancellor of the Board of Regents of the American College of Critical Care Medicine.
- Dr. Pastores’ research interests include clinical studies of sepsis/septic shock, pneumonia, and ARDS in patients with cancer, management of toxicities of checkpoint inhibitors and CAR-T cell therapy, ICU staffing and advanced critical care organizations, and the use of corticosteroids in sepsis and ARDS.
- He has published over 300 articles, book chapters, and abstracts. He was the recipient of the 2013 and 2021 Distinguished Service Award and 2016 Safar Global Partner Award from the Society of Critical Care Medicine.
- He is currently on the editorial boards of Critical Care Medicine and the Journal of Critical Care.
Luis Eduardo Pino Villarreal
MD, MSC, MBA
- Internal Medicine (2008, Militar University)
Hematology and Clinical Oncology (2013, Militar University)
- MSc Molecular Oncology (2013, CNIO Spain)
- Health Business Administration MBA (2019, EAN)
- Pharmacoeconomics Diploma (2021, Rosario University)
- AI in Healthcare Executive Program (2021, MIT Sloan School)
- AI and Machine Learning Program (2022, U U Texas)
- Institutional Oncologist Fundación Santafe (2015 - )
- National Cancer Advisor - Sanitas EPS (2019 - )
- Founder and Scientific Director MAIA Health (2019-2022)
- Founder and CEO AIpocrates and OxLER SAS (2022-)
- Deputy Director of Research and Teaching HOMIC 2017 - 2018
MD, MSc, WHO - IARC
- Cancer Surveillance Branch, International Agency for Research on Cancer
- Marion Piñeros is a medical doctor from the Universidad el Rosario in Colombia and Master of Public Health from the London School of Hygiene and Tropical Medicine in London.
- Before working at the International Agency for Research on Cancer she worked for one year at the Programme for Action on Cancer Therapy (PACT) from the International Agency of Atomic Energy (IAEA) and fourteen years at the National Cancer Institute in Colombia, where she led the public health group, being strongly involved in cancer surveillance and control.
- Her main interest has been the production, dissemination and use of information for cancer control.
- She has advocated for a clear understanding among stakeholders of the role of PBCR in cancer surveillance and has contributing to descriptive epidemiology studies of cancer in different areas.
- She leads the IARC Regional Hub for Cancer Registration in Latin America, providing and coordinating training, tailored support to cancer registries as well as fostering networks and data dissemination for cancer control in the countries of the region.
Professor Bernhard Riedel
MB.ChB, FCA, FANZCA, FASE, MMed, MBA, PhD
- Bernhard is an academic anaesthesiologist and the Director of the Department of Anaesthesia, Perioperative Medicine, and Pain Medicine at Peter MacCallum Cancer Centre in Melbourne, Australia.
- He holds a Professorial appointment at the University of Melbourne.
- Prior appointments include Professor and Deputy Chair, Anesthesiology and Intensive Care, The University of Texas M.D. Anderson Cancer Centre (USA)
Professor of Cardiothoracic Anesthesiology, Vanderbilt University (USA).
- Consultant Anaesthetist, Royal Brompton & Harefield NHS Trust (UK).
- His research is focused on enhanced preoperative risk stratification and optimization of modifiable risk (prehabilitation) to reduce the ‘hidden pandemic’ of complications and death after major surgery.
- Specific to cancer surgery, he is a thought leader in a global collaborative on oncoanaesthesia. In this regard, his research explores the interaction of perioperative adrenergic-inflammatory response and anaesthetic technique on cancer progression.
- His research program has resulted in 75 research grants (>$16M), >200 peer-reviewed scientific publications (including Lancet, New England Journal Medicine, JAMA, Cancer Research, Nature Reviews, British Journal Anaesthesia - h-index 40, i10index 80, and cited >6,200 times).
- In addition, he has edited three books, including ‘Acute Care of the Cancer Patient’ and has delivered >200 lectures at national/international conferences. Effective mentorship has resulted in 37 awards to team members for clinical service, quality improvement, and research.
- Dr. Celia R. Ledet is a general surgeon and Assistant Professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center.
- She earned her medical degree from Georgetown University School of Medicine and completed surgical residency and fellowship at Baylor College of Medicine in Houston, Texas.
- She is double board certified in General Surgery and Surgical Critical Care.
- Her clinical and academic focus is on acute care general surgery in the cancer population.
- In addition, she has a special interest in hernia repair, specifically minimally invasive complex abdominal wall reconstruction.
Macarena Rodríguez Vidal
- Dr. Macarena Rodriguez is an Interventional Pulmonologist Doctorado de la Universidad Pontificia Catolica de Chile.
- Fellowship in Pulmonary Diseases, from the Instituto Nacional del Tórax, Universidad de Chile.
- Interventional Pulmonology Fellowship MD Anderson Cancer Center MSc in Epidemiology.
- London School of Hygiene and Tropical Medicine, London, UK Currently.
- She is the Head of the Unit of Interventional Pneumology Clinica Alemana of Santiago – and the National Cancer Institute, Chile.
- Department of Critical Care and Graduate Program in Translational Medicine, D’Or Institute for Research and Education, Rio de Janeiro, Brazil
- Department of Research and Development, Epimed Solutions, Rio de Janeiro, Brazil
Professor Charles Sprung
MD, JD, MCCM
- Is the Director Emeritus of the General Intensive Care Unit in the Department of Anesthesiology and Critical Care Medicine at Hadassah Hebrew University Medical Center in Jerusalem, Israel where he has worked for the last 34 years.
- He was previously the Director of the Section of Critical Care Medicine in the Department of Medicine at the VA Medical Center and the University of Miami for 13 years.
- Professor Sprung was the Chairman of the Committee on Ethics Section of the US Society of Critical Care Medicine from 1987 to1994 and of the European Society of Intensive Care Medicine (ESICM) from 1996 to 2001 and 2004 to 2007.
- He was the Chairman of the Israel Society of Critical Care Medicine from 1990 to 1993 and the Chairman of the Medical and Scientific Subcommittee of the Israel Terminally Ill Law-2005.
R. Scott Stephens
- Scott Stephens is an Associate Professor of Medicine and Oncology in the Division of Pulmonary and Critical Care Medicine at the Johns Hopkins University School of Medicine and is the medical director of the Oncology and Bone Marrow Transplant Intensive Care Unit at the Johns Hopkins Hospital and the Sidney Kimmel Comprehensive Cancer Center.
- Dr. Stephens is a graduate of Amherst College and the University of Pennsylvania School of Medicine, and completed residency training in internal medicine and fellowship training in pulmonary and critical care medicine at Johns Hopkins University.
- His clinical and research interests lie in oncologic critical care and severe respiratory failure, with specific focus on respiratory failure after hematopoietic stem cell transplant, complications of immune effector cell therapy, and extracorporeal support for severe respiratory failure. He also has strong interests in critical care education, multidisciplinary critical care delivery, ICU administration, and system-level organization of critical care efforts.
- Is Professor of Medicine and Intensive Care.
- She is the Chairperson of the Department of Internal Medicine, Medical Intensive Care Unit and Sepsis Research Center in Hacettepe University Faculty of Medicine, Ankara, Turkiye.
- She will be chairing the 16th World Intensive and Critical Care Congress on 26-30 Aug 2023, in Istanbul. She is the Chief Editor of Journal of Critical and Intensive Care.
- She is the Founder President and the current Council Member of the Society of Turkish Intensivists (2005-).
- She was in the Council of the World Federation of Intensive and Critical Care between 2013 and 2019 (Treasurer 2017-2019), and was the former Deputy Chairperson of Health Services Research and Outcome Section and a member of the Research Committee of the European Society of Intensive Care Medicine (2019-2022).
- Her main interests are acute respiratory failure; post-intensive care syndrome; intensive care infections; ICU organisation, staffing; quality of care; rapid response system; intensive care epidemiology and outcome.